Posted by Brigham and Women's Hospital March 4, 2014
Thanks to increased awareness, the death rate from colorectal cancer has been dropping for more than 20 years.
Contributor: Dr. Jeffrey Meyerhardt is the clinical director of the Gastrointestinal Cancer Treatment Center at Dana-Farber/Brigham and Women’s Cancer Center.
Colorectal cancer is the third most common cancer in the U.S., with about 134,490 new patients diagnosed in the U.S. in 2016. But thanks to increased awareness about screenings, the death rate from colorectal cancer has been dropping for more than 20 years.
“For the most part, colorectal cancer is a curable and preventable disease,” says Dr. Jeffrey Meyerhardt, clinical director of the Gastrointestinal Cancer Treatment Center at Dana-Farber/Brigham and Women’s Cancer Center. “It is a cancer where we have very good data that shows screening prevents disease and saves lives.”
Read More »
Posted by Brigham and Women's Hospital December 27, 2012
One of these may reduce your risk of cancer - but not heart disease.
Recently, we published the results from the first large-scale clinical trial to evaluate the long-term effects of multivitamins for men. When it comes to cancer researchers found that taking a daily multivitamin modestly but significantly reduced the risk of developing cancer and possibly reduced cancer-related deaths among men over 50; however, they also found that multivitamins did not appear to reduce the risk of cardiovascular disease in the same group of men.
“The findings from our large clinical trial do not support the use of a common daily multivitamin supplement for the sole purpose of preventing cardiovascular disease in men,” said Dr. Howard D. Sesso, lead author and an associate epidemiologist in the Division of Preventive Medicine at BWH. “The decision to take a daily multivitamin should be made in consultation with one’s doctor and consideration given to an individual’s nutritional status and other potential effects of multivitamins, including our previously reported modest but significant reduction in cancer risk.”
Read More »